Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

The impact of COVID-19 on chronic disease management and the implications for pharma marketing

The impact of COVID-19 on chronic disease management and the implications for pharma marketing

On February 11, 2020, COVID-19 was officially named by the World Health Organisation (WHO). Since then the novel coronavirus causing it, (a severe acute respiratory syndrome) has left its mark on almost every country in the world.

Therapy Watch, our syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management. In this white paper, we share some of the insights and consider future impact.

read more »

  • Posted by Dan Coffin
  • July 24, 2020
  • Articles

What’s next? How behavioural science can support pharma’s future

What’s next? How behavioural science can support pharma’s future

Dan Coffin, Director explains why now is an opportune time for pharma marketers to embrace behavioural science. Published in PME Magazine, July 2020.

A marketer’s goal is to encourage customers to change their behaviour and adopt the brand. It can be a tough challenge. Yet the pandemic has required billions of people to change their behaviour in the blink of an eye. The reality is that customers have never been so open to change. For pharma marketers, understanding and shaping these changing behaviours could be key to differentiating and optimising their brand potential. This is an opportune time to embrace behavioural science which, in recent years, has been successfully adopted and used by government and private enterprise as a means to enable favourable behaviours that benefit brands. It’s essentially about tapping into the unconscious biases and heuristics we each unknowingly hold when making decisions. If we can understand these biases at play, then we can provide nudges to effect a positive change in behaviour.

read more »

Infographic - Emerging markets: Our experience and expertise

Infographic - Emerging markets: Our experience and expertise

Research Partnership has a dedicated team of healthcare research experts specialising in emerging markets with an established team of senior consultants, collaborating with you to deliver actionable and impactful insights that makes a difference to your business. Find out about our team of emerging market experts with this infographic outlining our experience and expertise across a vast number of regions.

read more »

  • Posted by Mariel Metcalfe
  • June 30, 2020
  • News

Research Partnership publishes new patient syndicated reports - Living with Ulcerative Colitis and Crohn’s Disease 2020

Research Partnership publishes new patient syndicated reports - Living with Ulcerative Colitis and Crohn’s Disease 2020

Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports provide pharmaceutical companies with a strong, foundational knowledge and up-to-date insights on the UC and CD patient journeys.   

read more »

  • Posted by Claire Fradet Aubignat
  • June 29, 2020
  • Articles

Not just another PSP: 5 top tips for evaluating your patient support programme

Not just another PSP: 5 top tips for evaluating your patient support programme

Evaluating PSPs before launch is critical. We present you with our top tips for conducting successful market research to ensure your PSP is successful and maximises value to your customers.

Did you know that, whilst there are a significant number of PSPs available to patients, only a small minority are actually used?  IMS (2015) found that 36 out of almost 200,000 mobile health apps comprised 50% of downloads - many of the rest must have very few users. So, a key challenge is to develop a PSP that is utilised, valued and has a definite real world impact on both the patient and HCP experience.

read more »